Vascular Endothelial Growth Factor Gene Polymorphisms in Age-related Macular Degeneration

American Journal of Ophthalmology

Volumn 145, Issue 6, 2008, Pages

  Lin, Jane Ming ^a   Wan, Lei ^a,c   Tsai, Yi Yu ^a   Lin, Hui Ju ^a   Tsai, Yushin ^b   Lee, Cheng Chun ^a   Tsai, Chang Hai ^a,c   Tseng, Sung Huei ^d   Tsai, Fuu Jen ^a,b,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; DNA; VASCULOTROPIN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 43949097221     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.01.027     Document Type: Article

References (39)

1. A.C. Bird The Bowman lecture: towards an understanding of age-related macular disease Eye 17 2003 457 466
2. N. Congdon B. O'Colmain C.C. Klaver Causes and prevalence of visual impairment among adults in the United States Arch Ophthalmol 122 2004 477 485
3. J. Marx Genetics A clearer view of macular degeneration Science 311 2006 1704 1705
4. M.R. VanNewkirk M.B. Nanjan J.J. Wang P. Mitchell H.R. Taylor C.A. McCarty The prevalence of age-related maculopathy: the visual impairment project Ophthalmology 107 2000 1593 1600
5. J.R. Vingerling I. Dielemans A. Hofman The prevalence of age-related maculopathy in the Rotterdam Study Ophthalmology 102 1995 205 210
6. R. Klein B.E. Klein K.L. Linton Prevalence of age-related maculopathy The Beaver Dam Eye Study Ophthalmology 99 1992 933 943
7. A.C. Bird N.M. Bressler S.B. Bressler An international classification and grading system for age-related maculopathy and age-related macular degeneration The International ARM Epidemiological Study Group Surv Ophthalmol 39 1995 367 374
8. R. Van Leeuwen C.C. Klaver J.R. Vingerling A. Hofman P.T. de Jong The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam Study Arch Ophthalmol 121 2003 519 526
9. A.O. Edwards Genetic testing for age-related macular degeneration Ophthalmology 113 2006 509 510
10. J.M. Seddon S. George B. Rosner M.L. Klein CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration Hum Hered 61 2006 157 165
11. S. Haddad C.A. Chen S.L. Santangelo J.M. Seddon The genetics of age-related macular degeneration: a review of progress to date Surv Ophthalmol 51 2006 316 363
12. J.A. Chapman C. Beckey Pegaptanib: a novel approach to ocular neovascularization Ann Pharmacother 40 2006 1322 1326
13. F.W. Fraunfelder Pegaptanib for wet macular degeneration Drugs Today 41 2005 703 709
14. U. Chakravarthy A.P. Adamis E.T. Cunningham Jr Year 2 efficacy results of two randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration Ophthalmology 113 2006 1508 1521
15. Z.F. Bashshur A. Bazarbachi A. Schakal Z.A. Haddad C.P. El Haibi B.N. Noureddin Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration Am J Ophthalmol 142 2006 1 9
16. P.J. Rosenfeld J.S. Heier G. Hantsbarger N. Shams Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration Ophthalmology 113 2006 623 632
17. J.L. Haines N. Schnetz-Boutaud S. Schmidt Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6 Invest Ophthalmol Vis Sci 47 2006 329 335
18. A.J. Churchill J.G. Carter H.C. Lovell VEGF polymorphisms are associated with neovascular age-related macular degeneration Hum Mol Genet 15 2006 2955 2961
19. A.N. Witmer G.F. Vrensen C.J. Van Noorden R.O. Schlingemann Vascular endothelial growth factors and angiogenesis in eye disease Prog Retin Eye Res 22 2003 1 29
20. M. Shahbazi A.A. Fryer V. Pravica Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection J Am Soc Nephrol 13 2002 260 264
21. T. Awata K. Inoue S. Kurihara A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes Diabetes 51 2002 1635 1639
22. P. Krippl U. Langsenlehner W. Renner A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk Int J Cancer 106 2003 468 471
23. W. Renner S. Kotschan C. Hoffmann B. Obermayer-Pietsch E. Pilger A common 936 C/T mutation in the gene for vascular endothelial growth factor plasma levels J Vasc Res 37 2003 443 448
24. M.I. Koukourakis D. Papazoglou A. Giatromanolaki G. Bougioukas E. Maltezos E. Sivridis VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non–small cell lung cancer Lung Cancer 46 2004 293 298
25. A. Stevens J. Soden P.E. Brenchley S. Ralph D.W. Ray Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promotor Cancer Res 63 2003 812 816
26. C.J. Watson N.J. Webb M.J. Bottomley P.E. Brenchley Identification of polymorphisms within the vascular endothelial growth factor ( VEGF ) gene: correlation with variation in VEGF protein production Cytokine 12 2000 1232 1235
27. G. Akiri D. Nahari Y. Finkelstein S.Y. Le O. Elroy-Stein B.Z. Levi Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription Oncogene 17 1998 227 236
28. N. Ferrara K.A. Houck L.B. Jakeman J. Winer D.W. Leung The vascular endothelial growth factor family of polypeptides J Cell Biochem 47 1991 211 218
29. S.X. Zhang J.X. Ma Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy Prog Retin Eye Res 26 2007 1 37
30. O. Tatar E. Kaiserling A. Adam Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes Arch Ophthalmol 124 2006 815 823
31. P.F. Lopez B.D. Sippy H.M. Lambert A.B. Thach D.R. Hinton Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration–related choroidal neovascular membranes Invest Ophthalmol Vis Sci 37 1996 855 868
32. A. Kvanta P.V. Algvere L. Berglin S. Seregard Subfoveal fibrovascular membranes in age-related macular degeneration expresses vascular endothelial growth factor Invest Ophthalmol Vis Sci 37 1996 1929 1934
33. P.-L. Lip A.D. Blann M. Hope-Ross J.M. Gibson G.Y. Lip Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology, and endothelial dysfunction Ophthalmology 108 2001 705 710
34. J.A. Wells R. Murthy R. Chibber Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularization Br J Ophthalmol 80 1996 363 366
35. M. Kliffen H.S. Sharma C.M. Mooy S. Kerkvliet P.T. de Jong Increased expression of angiogenic growth factors in age-related maculopathy Br J Ophthalmol 81 1997 154 162
36. R.J. Klein C. Zeiss E.Y. Chew Complement factor H polymorphism in age-related macular degeneration Science 308 2005 385 389
37. T. Sepp J.C. Khan D.A. Thurlby Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers Invest Ophthalmol Vis Sci 47 2006 536 540
38. L.I. Lau S.J. Chen C.Y. Cheng Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients Invest Ophthalmol Vis Sci 47 2006 3242 3246
39. R. Narayanan V. Butani D.S. Boyer Complement factor H polymorphism in age-related macular degeneration Ophthalmology 114 2007 1327 1331